MedTrace Logo

Effect of a Meal Replacement on Weight Loss Obesity Patients With Metabolic Syndrome

NCT02626741 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2015-12-10

No results posted yet for this study

Summary

The purpose of this study is to determine whether meal replacement, SlimWell ®, is effective in the treatment of obesity patients with metabolic syndrome.

Conditions

  • Abdominal Obesity-Metabolic Syndrome

Interventions

DIETARY_SUPPLEMENT

meal replacement group

The participants will receive SlimWell 60 grams per meal for 2 meals per day plus life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.

BEHAVIORAL

control group

The participants will receive only life style modification including educational sessions of exercise, dietary intake, food record. The duration is 3 months.

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Kusuma Chaiyasoot, MD · Mahidol University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-02-29
Completion
2016-04-30

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02626741 on ClinicalTrials.gov